DeCaprio David 4
4 · FIREFLY NEUROSCIENCE, INC. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
AIFF President David DeCaprio Receives 44,872-Share Award
What Happened
David DeCaprio, President & COO and a director of Firefly Neuroscience, reported the vesting of 44,872 restricted stock units (RSUs) on March 10, 2026. The Form 4 lists the transaction as an award/acquisition (code A) at $0.00 per share (reported value $0). These vested RSUs are part of a larger April 18, 2025 grant under the company’s 2024 Long‑Term Incentive Plan.
Key Details
- Transaction date: 2026-03-10; reported on Form 4 filed 2026-03-12.
- Transaction type/price: Award (A) of 44,872 shares at $0.00 per share (reported $0).
- Shares owned after transaction: Not disclosed in the filing.
- Footnote: On 4/18/2025 DeCaprio was granted 263,952 RSUs; on 3/10/2026 the Compensation Committee determined performance conditions were met for vesting of 44,872 of those shares.
- Timeliness: Filing appears timely (reported within two business days of the transaction).
Context
These were performance‑based RSUs vesting under the company’s long‑term incentive plan—not an open‑market purchase or sale. Awards like this are a form of executive compensation and do not, by themselves, indicate the insider bought or sold shares in the market.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-10+44,872→ 77,866 total
Footnotes (1)
- [F1]On April 18, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan for 263,952 shares of Common Stock. On March 10, 2026, the Compensation Committee of the board of directors of the Issuer determined that the performance conditions had been met for the vesting of 44,872 of these shares.